4Kolars JC, Stetson PL, Rush BD, et al.Cyclosporine A metabolism by P450Ⅲ A in rat enterocytes another determinant of oral bioavailability [ J ]. Transplantation, 1992,53 : 596-602.
5Fija JF, Webber IR, Back DG. Cyclosporine metabolism by gastrointestinal mucosa[J]. Br. J. Clin. Pharmacol, 1991, 31:344-346.
6Wenger Rm. Structures of cyclesporine and its metabolites [J]. Transpl. Proc. 1990, 22(3): 1104-1108.
7Kim PCW, Cohen Z, Wong PY, et al. Cyclosporine A vs Cyclosporine A metabolites:comparisons of in vivo and in vitro immunosuppressive and toxic effects [ J ]. Transpl.Proc. 1990, 22 (6): 2487-2490.
8Duncan S, Liu WT, Lery JW, et al. Isolation and identification of two cycloporine aidehydic metabolites from the bile of a liver transplant recipient during an acute nephrotoxic episode [J]. Transpl. Proc. 1994, 26 (5):2899-2901.
9Sewing KF. Pharmacokinetics, dosing principles, and blood level monitoring of FK506 [J].Transpl. Proc, 1994, 26 (6): 3267-3269.
10Shiraga T, Matsuda M, Nagase K, et al.Metabolism of FK506 a potent immunosuppressive agent , by cytochrome P450Ⅲ A enzymes in rat , dog and human live mierosomes [J].Biochem. Pharmacol. 1993, 47: 727-735.
